{"id":"W4401695143","doi":"10.1136/ard-2024-225686","title":"Efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients with systemic lupus erythematosus: the phase 3, randomised, placebo-controlled BLISS-BELIEVE study","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"Medical Research Council","keywords":"Medicine; Belimumab; Rituximab; Placebo; Internal medicine; Adverse effect; Phases of clinical research; BLISS; Dermatology; Clinical trial; Immunology; Antibody; Alternative medicine; B-cell activating factor; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001032553,0.0003135744,0.001603899,0.0002378958,0.00008259925,0.00004371243,0.0002815948,0.00005583179,0.00002568226],"category_scores_gemma":[0.0005020588,0.0001418021,0.0001634059,0.0004487055,0.0004902274,0.0001065055,0.0001100411,0.0001687288,0.00000117476],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003115285,"about_ca_system_score_gemma":0.0003193806,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001092622,"about_ca_topic_score_gemma":0.00001833455,"domain_scores_codex":[0.9965242,0.0005961854,0.001091388,0.0003577579,0.001115928,0.0003145563],"domain_scores_gemma":[0.9963296,0.001889505,0.0005702183,0.0007469367,0.0003256971,0.000138046],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7943931,0.01501757,0.1485338,0.01138164,0.006370654,0.00007867333,0.01539501,0.0001227511,0.0001790698,0.0001347059,0.00009960158,0.008293523],"study_design_scores_gemma":[0.9329168,0.008381297,0.01141425,0.03314707,0.001795314,0.00223349,0.007345156,0.001658671,0.0004595674,0.0002784595,0.000002761286,0.0003672082],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9776239,0.01276397,0.00001733913,0.0002749821,0.00006036135,0.009090956,0.00009610763,0.0000264846,0.0000458731],"genre_scores_gemma":[0.998521,0.001101065,0.00001650989,0.00001607397,0.0000130165,0.000208421,0.000008554259,0.00004975516,0.00006554584],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1385237,"threshold_uncertainty_score":0.5782523,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02016763466357224,"score_gpt":0.302727449078991,"score_spread":0.2825598144154188,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}